Background: PERFORM-TSIX is a multicenter, international diagnostic study to evaluate the diagnostic value of Roche's sixth generation high-sensitivity troponin assay. Patients presenting to the emergency department of the University Hospital Basel with chest pain or suspected acute coronary syndrome will be included. Blood samples are taken at entry, after 1, 2, 3 and 6 hours. After 30 and 180 days, the study participants are contacted for a follow-up. The study duration is planned for the period from 09.2022 to 10.2023 Sponsor: Roche Trial Status: Recruiting Enrolling Centers: Worldwide: 1700 participants (May 2023) Core Study Team Basel:
© Christian Mueller, 2012 - 2024 │ DisclaimerImprintWebmaster │ Last Update: July 2024
Michael Freese
Lourdes Herraiz Recuenco